Chemoinformaics analysis of 24-epi-Brassinolide
| Molecular Weight | 480.686 | nRot | 5 |
| Heavy Atom Molecular Weight | 432.302 | nRig | 8 |
| Exact Molecular Weight | 480.345 | nRing | 4 |
| Solubility: LogS | -4.883 | nHRing | 1 |
| Solubility: LogP | 4.337 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 82 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 83.5781 |
| nHD | 4 | BPOL | 50.7579 |
| QED | 0.538 |
| Synth | 1.757 |
| Natural Product Likeliness | -0.237 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.341 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.489 |
| MDCK | 0.0000327 |
| BBB | 0.043 |
| PPB | 0.941151 |
| VDSS | 1.084 |
| FU | 0.0319878 |
| CYP1A2-inh | 0.959 |
| CYP1A2-sub | 0.415 |
| CYP2c19-inh | 0.908 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.751 |
| CYP2c9-sub | 0.468 |
| CYP2d6-inh | 0.604 |
| CYP2d6-sub | 0.111 |
| CYP3a4-inh | 0.476 |
| CYP3a4-sub | 0.116 |
| CL | 12.528 |
| T12 | 0.297 |
| hERG | 0.221 |
| Ames | 0.007 |
| ROA | 0.002 |
| SkinSen | 0.711 |
| Carcinogencity | 0.087 |
| EI | 0.987 |
| Respiratory | 0.028 |
| NR-Aromatase | 0.097 |
| Antiviral | Yes |
| Prediction | 0.668803 |